IGOR NEDIC: Open Payments
NPI 1316913304 · MARYSVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 16 payments from 8 companies in 2025. Trend: 2023 $310 · 2024 $246 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $123 |
| Astellas Pharma US Inc | 3 | $49 |
| Amgen Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Alkermes, Inc. | 1 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
Products named: CAPLYTA, Veozah, TRELEGY ELLIPTA, VIVITROL, PURIFIED CORTROPHIN GEL, EVENITY, XIFAXAN, Rybelsus.
Industry payments across MI — which companies pay providers there.
